EGIPH
Our Journey
Ezekiel Golan Intellectual Property Holdings and Research Ltd. (EGIPH) was incorporated in British Columbia on July 23, 2018. From its inception, the company served as the central holding entity for the entire portfolio of granted patents invented or co-invented by Ezekiel Golan.
Over its first years, EGIPH functioned as a structured repository and commercialization instrument for patents spanning across the disciplines of genetics, pharmacology, mycology, horticulture, chemical design, and behavioural neuroscience. These inventions were gradually licensed and sold to private and public companies, research institutions, and government bodies in varying jurisdictions.
Our Journey
Continued
With the maturation and sale of its portfolio, the company reached a natural inflection point.
EGIPH is now entering a new phase—one defined not by stewardship of past inventions, but by the creation of a new generation of intellectual property. This second generation portfolio is being developed with a focus on the challenges of the modern age, approached through the lens of an independent, multidisciplinary discovery scientist.
Our Journey
Into the Future
The company’s current direction reflects a return to first principles: identifying difficult, overlooked or underaddressed problems, pursuing unconventional lines of inquiry, and generating original solutions with real-world impact.
EGIPH is therefore shifting its weight from holdings to being an active engine of invention—building the next body of work that will define a part of the future.
